Brian R. Haas - Concepedia

Author

Brian R. Haas

University of Alabama at Birmingham

Also Known As

B Haas, B.R. Haas, Brian Haas, Brian R Haas, Brian R. Haas, Haas, B., Haas, Brian

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham University of Washington

About

Brian R. Haas is an author at University of Alabama at Birmingham specializing in glioma, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	743
2	Cell Biology	4	4	205
3	Cellular Physiology	2	2	149
4	Social Sciences	1	1	538
5	Neurology	1	1	538

Brian R. Haas

Publications

970

Citations

H-Index

Page 1

	Year	Citations
Glutamate release by primary brain tumors induces epileptic activity Susan Buckingham, Susan L. Campbell, Brian R. Haas, Nature Medicine Neuro-oncologyNeurophysiologyNeuropharmacologyNeuroscienceNeurology	2011	538
Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 Reduces Glioma Invasion Brian R. Haas, Harald Sontheimer Cancer Research	2010	131
Water permeability through aquaporin-4 is regulated by protein kinase C and becomes rate-limiting for glioma invasion Eric S. McCoy, Brian R. Haas, Harald Sontheimer Neuroscience Glioma InvasionOsmotic StressProtein Kinase CGliomaOsmoregulation	2009	85
Premotor biomarkers for Parkinson's disease - a promising direction of research Brian R. Haas, Tessandra H. Stewart, Jing Zhang Translational Neurodegeneration	2012	70
With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume Brian R. Haas, Vishnu Anand Cuddapah, Stacey Watkins, American Journal of Physiology-Cell Physiology High-grade GliomasCancer BiologyGliomaCellular PhysiologyTumor Biology	2011	64
Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells Philippe Diaz, Eric A. Horne, Cong Xu, European Journal of Medicinal Chemistry Neuro-oncologyGliomaModified CarbazolesTumor TargetingAnti-cancer Agent	2018	30
ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme Allison E. Cherry, Brian R. Haas, Alipi V. Naydenov, Molecular Cancer Therapeutics Current Antitubulin AgentsNeuro-oncologyTumor BiologyTherapeutic PotentialGlioma	2016	26
Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival Youn‐Jung Kang, Barbara B. Balter, Eva Csizmadia, Nature Communications	2017	26

Page 1